Endothelial thrombomodulin downregulation caused by hypoxia …
WEBAug 18, 2021 · Pulmonary endothelial cells become dysfunctional during COVID-19, showing a loss of thrombomodulin expression related to severe thrombosis and infiltration, and endothelial cell dysfunction might be caused by a pathologic condition in COVID-19 …
See results only from thelancet.comEndotheliopathy in COVID-19 …
We show that endotheliopathy is widespread among hospitalised patients …
Biomarkers of coagulation, endothelial, platelet function, and ...
WEBJan 23, 2024 · Markers of endothelial activation [Soluble thrombomodulin (sTM), von …
Endothelial dysfunction in COVID-19: an overview of evidence ...
WEBOct 17, 2022 · Thus, COVID-19 is deemed as a (micro)vascular and endothelial disease. …
Endothelial thrombomodulin downregulation caused by hypoxia …
WEBJan 13, 2022 · Endothelial thrombomodulin downregulation caused by hypoxia …
Searches you might like
Thrombomodulin as an early marker of endotheliitis in COVID-19
WEBJun 30, 2020 · From the pathophysiological perspective, elevated soluble …
Endothelial thrombomodulin downregulation caused by hypoxia …
WEBPulmonary endothelial cells of COVID-19 patients showed increased expression of pro …
Coagulation Disorders and Thrombosis in COVID-19 Patients and …
WEBFeb 1, 2022 · Endothelial cell activation and dysfunction play a pivotal role in the …
Thrombocytopathy and endotheliopathy: crucial contributors to …
WEBNov 19, 2020 · Age has an important role in COVID-19 pathogenesis; young patients …
COVID-19 is, in the end, an endothelial disease
WEBSep 3, 2020 · The endothelial monolayer that lines the intima of arteries, veins, and …
Endotheliopathy in COVID-19-associated coagulopathy …
WEBJun 30, 2020 · We show that endotheliopathy is widespread among hospitalised patients with COVID-19 and is more extensive in critically ill patients than in non-critically ill patients.
Skip to content
